Newsfiscal.ai
Mizuho Securities Maintains Buy Rating on REGENXBIO, Adjusts Price Target
· Published
Article summary
Mizuho Securities analyst Graig Suvannavejh maintained a 'Buy' rating on REGENXBIO shares while lowering the price target from $22 to $19.
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…